At a glance
- Originator Roche
- Class Antineoplastics; Small molecules
- Mechanism of Action Angiogenesis inhibitors; Phosphotransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Solid-tumours in USA
- 10 May 2007 Data presented at the 98th Annual Meeting of the American Association for Cancer Research (AACR-2007) added to the Cancer pharmacodynamics section ,,
- 14 Nov 2006 Phase-I clinical trials in Solid tumours (unspecified route)